跳至主要内容
临床试验/KCT0007397
KCT0007397尚未招募未知

Comparison between abluminal biodegradable polymer ultrathin sirolimus-eluting stent and durable-polymer everolimus-eluting stent (GENOSS randomized clinical trial)

Samsung Medical Center0 个研究点目标入组 850 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
850

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 100(Year)(—)
性别
All

入选标准

  • ? 19 years of age or older
  • ? Patients diagnosed with stable coronary artery disease or acute coronary syndrome and with more than 50% coronary stenosis requiring stent insertion
  • ? A person who can voluntarily sign the consent form

排除标准

  • ? If the following drugs are irritable or contraindicated (aspirin, clopidogrel, ticagrelor, prasugrel, heparin, sirolimus, or everolimus)
  • ? a pregnant woman
  • ? A person who is expected to have a life expectancy of less than one year due to non-heart disease or less compliant with treatment (as determined by medical judgment by the investigator)
  • ? Patients who refused to participate in the study

研究者

相似试验